SECURITIES & EXCHANGE COMMISSION
Washington D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
Arista Investors Corp.
- --------------------------------------------------------------------------------
(Name of Issuer)
Class A Common Stock, $0.01 Par Value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
040408106
--------------
(CUSIP Number)
December 31, 1999
-----------------------------------------------------
Date of Event Which Requires Filing of this Statement
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|_| Rule 13d-1(b)
|_| Rule 13d-1(c)
|X| Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No. 040408-10-6 13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Bernard Kooper
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
19.3%
494,800 shares
--------------------------------------------------------------
Number of 6 SHARED VOTING POWER
Shares 1.2%
Beneficially 30,400 shares
Owned By --------------------------------------------------------------
Each 7 SOLE DISPOSITIVE POWER
Reporting 19.3%
Person 494,800 shares
With --------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
1.2%
30,400 shares
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
525,000 shares
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|_|
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
20.4%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
Page 2 of 4
<PAGE>
CUSIP No. 040408-10-6 13G
This statement constitutes Amendment No. 2 to the Schedule 13G previously
filed by the Reporting Person. No changes in any information previously reported
have occurred, except as set forth in this or prior Amendments.
Item 4. Ownership.
(a) Amount Beneficially Owned: 525,200(1),(2) shares
(b) Percent of Class: 20.4%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 494,800 shares
(ii) shared power to vote or to direct the vote: 30,400(1) shares
(iii) sole power to dispose or to direct the disposition of:
494,800 shares
(iv) shared power to dispose or to direct the disposition of:
30,400(1) shares
- ----------
(1) Includes 30,400 shares of Class A Common Stock owned by Arlyne Kooper,
wife of Bernard Kooper.
(2) On June 14, 1996, Mr. Kooper granted the Company an option to acquire
all of his shares of Class B Common Stock at any time before June 14, 2001. On
May 4, 1999, the Class A Directors of the Board of Directors exercised the
option, and thereafter delivered to Mr. Kooper the fair market value of such
shares.
Page 3 of 4
<PAGE>
CUSIP No. 040408-10-6 13G
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 11, 2000
-------------------------------------
Date
/s/ Bernard Kooper
-------------------------------------
Signature
Bernard Kooper
-------------------------------------
Name/Title
The original statement shall be signed by each person on whose behalf the
statement is filed or his authorized representative. If the statement is signed
on behalf of a person by his authorized representative (other than an executive
officer or general partner of the filing person), evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement, provided, however, that a power of attorney for this purpose
which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or
printed beneath his signature.
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 240.13d-7 for other
parties for whom copies are to be sent.
Attention: Intentional misstatements or omissions of fact constitute Federal
criminal violations (See 18 U.S.C. 1001).
Page 4 of 4
